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Abstract
Objective—To evaluate antiviral properties of blackberry extract against herpes simplex virus
type 1 (HSV-1) in vitro.
Methods—HSV-infected oral epithelial (OKF6) cells and cell-free virus suspensions were
treated with blackberry extract (2.24 to 1400 μg/mL) and virus yield and infectivity were
quantified by direct plaque assay.
Results—Blackberry extract ≥ 56 μg/ml inhibited HSV-1 replication in oral epithelial cells by >
99% (p < 0.005). Concentrations ≥ 280 μg/ml were antiviral when the extract was added after
virus adsorption and entry. Exposure of cell-free virus to ≥ 280 μg/ml blackberry extract for 15
minutes at room temperature was virucidal (p = 0.0002). The virucidal effects were not due to pH
changes at concentrations up to 1500 μg/ml.
Conclusions—Blackberry extract inhibited the early stages of HSV-1 replication and had potent
virucidal activity. These properties suggest that this natural fruit extract could provide advantage
as a topical prophylactic/therapeutic agent for HSV infections.
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Herpes simplex virus (HSV) is an epitheliotropic virus that infects children and the majority
of adults.1, 2 Infection of epithelial cells (i.e., mucosa and skin) results in de-envelopment,
rapid replication and spread to adjacent cells and nerve cell endings. Uptake of virions by
nerve endings permits the virus to travel retroaxonally to the nerve cell bodies within the
trigeminal ganglion, whereupon a quiescent state is established.3, 4 HSV DNA resides long-
term within the neuronal nuclei in a state that permits periodic reactivation and
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recrudescence of progeny virus.5, 6 The ability of the virus to hide within relatively immune
privilege sites makes elimination of this virus difficult.
Therapeutic options for HSV infections include the use of topical or systemic antiviral
agents.7–11 Topical agents have the potential advantages of direct contact and disruption of
various aspects of the virus life cycle, however most commercially available topical agents
do not penetrate effectively and thus have been shown to only have minor benefit in limiting
lesion eruption and duration.11–14 Also, topical antivirals can be expensive to use, especially
since they often require frequent and recurrent applications. As an alternative, naturally
occurring antiviral biochemicals found in plants and fruits could be less costly and more
efficacious to use. To date, extracts from seeds, plants, roots and fruits have been shown to
have antiviral activities.15–21 Of note, a large number of small molecules, like phenolics,
polyphenols, and flavonoids found in fruits have been reported to be active anti-herpetic
agents.16
Previously, our lab has shown that blackberries, which are rich in phenolics, polyphenols,
and flavonoids have antioxidant, anti-inflammatory and antiproliferative properties.22, 23
However, to our knowledge, scientific studies on the antiviral properties of blackberry
extract have not been reported. In as much as HSV infections remain a global healthcare
issue, we sought to investigate the antiviral effects of the extract against this well recognized
viral pathogen.
Methods
Cell culture and virus infectivity assays
The immortalized keratinocyte cell line OKF6/hTERT-2 (OKF6), established by ectopic
expression of the telomerase catalytic subunit (hTERT) in cells from normal oral mucosal
epithelium, was obtained from Dr. James Rheinwald, Harvard Medical School.24 Vero cells
were obtained from American Type Culture Collection (Rockville, Md). Cells were plated in
6-well tissue culture dishes at 3.75 and 6.25 X 105 cells/well, respectively, in Ker-SFM
media and incubated at 37°C in a humidified incubator with 5% CO2. The following day
cells were inoculated with HSV-1 strain 17+, obtained from N. Fraser of the Wistar Institute,
Philadelphia, at a multiplicity of infection (MOI) of ≤ 0.05 and incubated at 37°C for 1 hr.
Following two rinses with phosphate buffered saline (PBS), fresh media was added and
incubation at 37°C was continued overnight. Twenty four hours post-inoculation, virus was
released by three freeze thaw cycles and virus yield was determined in duplicate by direct
plaque assay on Vero cell monolayers as we have previously described.25 In the viral
replication inhibitory assays, triplicate cultures were supplemented with blackberry extract
at the times (during adsorption, after removal of virus inoculums or throughout) and
concentrations indicated. In the virucidal assays, cell-free virus suspensions (25,000 –
50,000 plaque forming units [PFU]/ml) were incubated with blackberry extract at 37°C for 1
hr or room temperature for 15 minutes. Virucidal assays were terminated at the indicated
times by dilution of reaction mixture to non-antiviral levels of blackberry extract (1:100
culture media). Virus infectivity was determined by the direct plaque assay and is presented
as the number of remaining PFUs relative to control treated virus suspensions.
Blackberry extract preparation—Hull blackberries (Rubus eubatus cv. “Hull”) were
grown at WindStone Farms (Paris, Kentucky). Seeds and skin were removed using a
Langsenkamp type 161 Colossal Pulper and the resultant puree was stored at −20ºC. Ethanol
extracts were obtained from the puree.22 Briefly, blackberry puree (10 g) was treated under
sonication for 30 min with 25 mL of extraction solvent of ethanol containing 0.01% HCl (v/
v). The supernatants were collected after filtration and dried by rotary evaporation at 40ºC.
The dried extract was resuspended in deionized water and filtered through a 20–25 μm filter
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paper and lyophilized to obtain dried ethanol extracts. Dried extracts was then redissolved in
deionized water as a stock solution (140 mg/mL, pH 1.9–2.0) and stored at −80ºC until use.
Results
Blackberry extract has anti-HSV-1 properties
To determine if blackberry extract has antiviral properties, its ability to inhibit the HSV-1
replication cycle in oral epithelial cells was evaluated. To broadly evaluate possible antiviral
activities cultures were maintained in the presence of increasing concentrations of
blackberry extract (0, 2.24, 11.2, 56, 280 and 1400 μg/ml) throughout the entire replication
cycle (i.e. adsorption, entry and production of progeny). As shown in Figure 1, blackberry
extract at 56 μg/ml significantly reduced HSV-1 yield by more than 99% (p = 0.004) and
progeny virus was not detectable in cultures treated with extract at concentrations ≥ 280 μg/
ml.
Higher concentrations are required for antiviral effects when blackberry extract is added
after HSV-1 entry
OKF6 cells were inoculated with virus (MOI of 0.05), incubated at 37°C for 1 hr and rinsed
2X with PBS prior to the addition of media supplemented with indicated concentration of
blackberry extract. Virus yield was assessed 24 hr post inoculation by titration on Vero cells
following 3 freeze-thaw cycles. Although 56 μg/ml blackberry extract dramatically reduced
virus yield when present throughout the entire replication cycle (Fig. 1), significant
reductions in virus yield when provided after the 1 hr adsorption and entry stage required
concentrations > 280 μg/ml (Fig. 2). Similar results were obtained in experiments where
Vero cells were infected with HSV-1 then exposed to blackberry extract (data not shown).
Incubation with blackberry extract for 1 hr at 37ºC inactivates HSV-1
The fact that blackberry extract at concentrations ≥ 56 μg/ml) greatly reduced virus yield (>
99%) when present throughout the inoculation and replication period but had no effect on
yield at concentrations ≤ 280 ng/ml when added following virus entry (Fig. 2) indicated that
blackberry extract may either inactivate the virus directly or block virus entry. To determine
in blackberry extract inactivates HSV-1, the extract was added to cell-free virus suspensions,
at the indicated concentrations, and incubated at 37°C for 1 hr to mimic the adsorption and
entry phase. Blackberry extract treated virus suspensions were diluted beyond the antiviral
concentration (1:100) with culture media and then virus infectivity was quantified by direct
plaque assay. In these experiments, even at the highest concentrations used the extract did
not affect the number of viable epithelial cells (data not shown). As indicated in Figure 3,
the amount of infectious HSV-1 virus remaining after 1 hr incubation at 37°C with 280 μg/
ml blackberry extract was significantly reduced compared to control cultures. Taken
together, these findings indicate a dose dependent antiviral effect of blackberry extract and
that this effect was most pronounced at the level of inactivation of cell-free virus.
Short-term incubation with blackberry extract at room temperature inactivates HSV-1
To further evaluate the effectiveness of blackberry extract on virus infectivity, HSV-1
suspensions were incubated with the indicated concentration of extract at room temperature
for 15 minutes to simulate intraoral use. HSV-1 infectivity was determined by direct plaque
assay on Vero cell monolayers. Similar to above, exposure of cell-free virus to ≥ 280 μg/ml
blackberry extract for as little as 15 minutes significantly reduced HSV-1 infectivity (Fig. 4).
Here higher concentrations of blackberry extract were required with ≥ 560 μg/ml blackberry
extract eliminating at least 50% of infectious virus and concentrations ≥ 1500 μg/ml
blackberry extract reducing > 90% of infectious virus. In as much as acidic pH is known to
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alter the infectivity of HSV-1, we quantified the pH of all the concentrations tested. Here the
diluted extract remained within neutral pH (i.e., > 6.8), suggesting that the antiviral effect
was more likely associated with the natural constituents within the blackberry extract than
pH.
Discussion
Blackberries are a natural and abundant fruit that grow in the wild and as cultivars. As early
as the 16th century, blackberry juice was used to treat infections of the mouth and eyes. The
extract, juice and leaves of blackberries are rich in polyphenols, which have anti-
inflammatory and antibacterial properties.23, 26 Here we further extended studies of
blackberry extract by investigating its antiviral properties and mechanism of action. These
studies add to the growing body of evidence that blackberry extract may provide benefit to a
large percentage of the world’s population by targeting a well recognized viral pathogen.
In the viral inhibition studies performed with blackberry extract we found that there was
near total inhibition of growth of HSV-1 in vitro at concentrations of > 56 μg/ml. The
antiviral effects were most noticeable when free virus was directly exposed to the blackberry
extract (i.e., before the infection), and less effective once HSV-1 had adsorbed and entered
epithelial cells (i.e., either OKF6 or Vero cells). This indicates that the extract has strong
antiviral effects that interfere with adsorption or entry into host cells and some intracellular
activity. While the minimum inhibitory concentrations were defined, it remains to be
determined whether the main inhibitory effect is due to impairment of viral proteins
involved in host cell receptor binding, adsorption and/or penetration of virions.
Polyphenols derived from plants have been shown to have antiviral activity (reviewed
in16, 27). Specifically, the flavonoids galangin, quercetin, procyanidin and pelargonidin as
well as procyanidin C-1 are found to be virucidal against HSV.21, 28–30 The antiviral effect
of these substances is greatest when used before virus adsorption30–32 which is consistent
with our findings. Blackberries are known to contain high amount of anthocyanins and
ellagitannins, thus those polyphenols in blackberry extract are likely individual or synergist
contributors to the antiviral effects observed.
In summary, our findings suggest that blackberry extract with its viral replication inhibitory
and rapid virucidal activities could be an effective topical treatment and/or prophylactic
agent for oral herpetic infections. These findings set the stage for future studies that would
isolate and identify the bioactive anti-HSV molecules in blackberry extract, and determine
whether the bioactive principle(s) in blackberry extract exhibit antiviral effects against
additional HSV strains and serotypes (i.e., HSV-2) in preclinical and toxicity evaluations.
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Figure 1. Blackberry Extract has antiviral properties
Oral epithelial cells were inoculated with HSV-1 strain 17+ (MOI = 0.05) in the presence of
the indicated concentration of blackberry extract. Following cell adsorption at 37°C and two
rinses with PBS, fresh cell culture media containing the indicated concentration of
blackberry extract was added and incubation was continued overnight at 37°C. Twenty four
hours post inoculation, cells were freeze-thawed 3 times and virus yield was quantified on
Vero cell monolayers by the direct plaque assay. Data represents the average +/− SD of
triplicate replication assays (i.e. n = 3). *, p < 0.005.
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Figure 2. Cell entry protects HSV-1 from antiviral effects of blackberry extract
HSV-1 strain 17+ was added to oral epithelial cells at an MOI = 0.05 and allowed to adsorb
and enter for 1 hr at 37°C. Fresh cell culture media, containing the indicated concentration
of blackberry extract, was added and incubation was continued overnight, followed by two
PBS rinses. Twenty four hours post inoculation, cells were freeze-thawed 3 times and virus
yield was quantified on Vero cell monolayers by the direct plaque assay. Data represents the
average +/− SD of triplicate replication assays (i.e. n = 3). *, p < 0.005.
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Figure 3. BBE inactivates HSV-1
Cell-free suspensions of HSV-1 (Strain 17+) were incubated at 37°C for 1 hr with the
indicated concentration of BBE. Infections virus was quantified by the direct plaque assay in
triplicate. Results are the average of two independent experiments (n = 2) and are presented
relative to untreated controls (100%). *, p < 0.005.
Danaher et al. Page 9













Figure 4. BBE inactivates HSV-1
Cell-free suspensions of HSV-1 (Strain 17+) were incubated at room temperature for 15
minutes with the indicated concentration of BBE. Infectious virus was quantified by the
direct plaque assay in triplicate. Results are the average of two independent experiments in
duplicate (n = 4) and are presented relative to untreated controls (100%). *, p < 0.005.
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